Insider · CIK 0001655016
Jonathan C Fox
Files at EWTX (Edgewise Therapeutics, Inc.). First filing Nov 13, 2025, latest Nov 13, 2025.
Jonathan C Fox files SEC Form 4 as director at EWTX (Edgewise Therapeutics, Inc.). Since Nov 13, 2025, Jonathan C Fox has reported 1 open-market buy worth $199k and 0 open-market sells worth $0, the latest filed on Nov 13, 2025.
A track record needs three past buys with six months of prices behind them; Jonathan C Fox has 0, so none is measured yet.
The newest scored trade: bought $199k of EWTX on Nov 11, 2025, filed Nov 13, 2025, scored 45 (moderate). In the last 12 months: 1 buy worth $199k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EWTX: Edgewise Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | EWTXbuy Edgewise Therapeutics, Inc. | $199k 10,700 shares | +82% | +88% from low-39% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +308 | $0.00 | $0 | 25,141 | 11 d ago |
| Jul 1, 2026 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +319 | $0.00 | $0 | 24,833 | Jul 1, 2026 |
| Jun 5, 2026 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,377 | $0.00 | $0 | 16,377 | Jun 16, 2026 |
| Apr 1, 2026 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +339 | $0.00 | $0 | 24,514 | Apr 3, 2026 |
| Jan 2, 2026 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +473 | $0.00 | $0 | 24,175 | Jan 5, 2026 |
| Nov 11, 2025 | EWTX Edgewise Therapeutics, Inc. | POpen-market purchase Common Stock | +10,700 | $18.64 | $199k | 23,702 | Nov 13, 2025 |
| Oct 1, 2025 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +728 | $0.00 | $0 | 13,002 | Oct 2, 2025 |
| Jul 1, 2025 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +858 | $0.00 | $0 | 12,274 | Jul 2, 2025 |
| Jun 16, 2025 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 18, 2025 |
| Apr 1, 2025 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Common Stock | +559 | $0.00 | $0 | 11,416 | Apr 3, 2025 |
Questions about Jonathan C Fox
Answered from the filings on this page, as of the latest one.
Is Jonathan C Fox buying or selling?
In the last 12 months Jonathan C Fox reported 1 open-market buy worth $199k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $199k of EWTX on Nov 11, 2025. Grants, option exercises and tax withholding are not counted.
How did Jonathan C Fox's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan C Fox has 0.
Where does Jonathan C Fox file Form 4?
Jonathan C Fox has filed Form 4 at EWTX (Edgewise Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.